Quality of life should be measured in clinical interventions to support economic evaluations

Quality of life should be measured in clinical interventions to support economic evaluations

This commentary is on the original article by Bekkers et al. on pages 1301–1307 of this issue.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Developmental medicine and child neurology 2020-11, Vol.62 (11), p.1234-1234
1. Verfasser: Shih, Sophy T F
Format: Artikel
Sprache:eng
Schlagworte:
Botulinum Toxins, Type A
Cost-Benefit Analysis
Humans
Quality of Life
Sialorrhea
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This commentary is on the original article by Bekkers et al. on pages 1301–1307 of this issue.
ISSN:0012-1622
1469-8749
DOI:10.1111/dmcn.14656